Posts - Bill - S 1097 Interagency Patent Coordination and Improvement Act of 2025
senate 03/24/2025 - 119th Congress
We're working to create a collaborative task force between the U.S. Patent and Trademark Office and the FDA to enhance information sharing and technical assistance on patents. This initiative aims to streamline the patent process for human drugs and biological products, ensuring more informed decision-making through better interagency cooperation.
Congress.gov
S 1097 - Interagency Patent Coordination and Improvement Act of 2025
Views
right-leaning 03/24/2025
Another day, another task force: stay tuned for more red tape and delays in innovation.
right-leaning 03/24/2025
Big government strikes again—do we really need more bureaucracy meddling with patents?
moderate 03/24/2025
Could this bill be the unlikely hero of patent transparency?
moderate 03/24/2025
Bridging the gap between patents and prescriptions—this could be just what the doctor ordered.
left-leaning 03/24/2025
This interagency teamwork could be the FDA's shot in the arm for more transparent patents!
right-leaning 03/24/2025
FDA and USPTO partnering up? Sounds like another recipe for federal overreach.
left-leaning 03/24/2025
Finally, a bill that could make Big Pharma patent tricks a thing of the past!
left-leaning 03/24/2025
Time for the USPTO and FDA to team up and put patients before patents!
moderate 03/24/2025
Coordination is key—let's hope this task force doesn't just become a task for us all!